Recovery From Anthracycline Cardiomyopathy After Long-term Support With a Continuous Flow Left Ventricular Assist Device

Mark Freilich, Dion Stub, Donald Esmore, Justin Negri, Robert Salamonsen, Peter Bergin, Angeline Leet, Meroula Richardson, Andrew Taylor, John Woodard, David Kaye, Franklin Rosenfeldt

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)


We report the clinical course of a 16-year-old girl in remission from non-Hodgkin's lymphoma who presented in cardiogenic shock due to a severe anthracycline cardiomyopathy. The patient was initially stabilized using central extracorporeal membrane oxygenation support, followed by conversion to a left ventricular assist device. Unexpected evidence of cardiac recovery 9 months after implant enabled device weaning during a 3-month period, culminating in successful device explantation 1 year after implant. The patient survives 18 months after explant in New York Heart Association class I, on conventional heart failure medical management and metabolic therapy.

Original languageEnglish
Pages (from-to)101-103
Number of pages3
JournalJournal of Heart and Lung Transplantation
Issue number1
Publication statusPublished - Jan 2009
Externally publishedYes

Cite this